Safety and Efficacy of Clenbuterol in Individuals With Late-onset Pompe Disease and Receiving Enzyme Replacement Therapy
Clinical trial NCT01942590 · COMPLETED
Trial details
- NCT number
- NCT01942590
- Sponsor
- Dwight Koeberl, M.D., Ph.D.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2016-09-02
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.